SCHEMBL820361

SCHEMBL820361

CC(C)c1cn(C)c2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.61
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
LMNA P02545 1/20 0.56
MAPT P10636 1/20 0.56
HTT P42858 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
KDM4E B2RXH2 1/20 0.53
GPR84 Q9NQS5 1/20 0.52
ALDH1A1 P00352 3/20 0.50
GAA P10253 1/20 0.50
NPC1 O15118 1/20 0.50
POLB P06746 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
IMPDH2 P12268 2/20 0.48
SRC P12931 2/20 0.48
HTR2A P28223 1/20 0.46
NQO2 P16083 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8591131 0.85 MEN1 (0.67) IDO1MEN1KMT2ALMNAMAPT
SCHEMBL31268114 0.85 MEN1 (0.67) IDO1MEN1KMT2ALMNAMAPT
SCHEMBL3904321 0.84 IDO1 (0.62) IDO1MEN1KMT2ALMNAMAPT
SCHEMBL19866686 0.84 IDO1 (0.57) IDO1MEN1KMT2ALMNAMAPT
SCHEMBL19054773 0.84 IDO1 (0.57) IDO1MEN1KMT2ALMNAMAPT
SCHEMBL12534047 0.82 IDO1 (0.60) IDO1MEN1KMT2ALMNAMAPT
SCHEMBL28346754 0.82 IDO1 (0.60) IDO1MEN1KMT2ALMNAMAPT
SCHEMBL16154384 0.81 MEN1 (0.60) IDO1MEN1KMT2ALMNAMAPT
SCHEMBL24723378 0.80 ALDH1A1 (0.54) IDO1MEN1KMT2ALMNAMAPT
SCHEMBL18856897 0.80 IDO1 (0.57) IDO1MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106414429-A Pyrazole compounds and their use as T-type calcium channel blockers 埃科特莱茵药品有限公司 2017-02-15 CN claimed
CN-103709171-B There is the pyridazine also derivative of [3,4-b] indole framework structure and synthetic method thereof WUHAN UNIVERSITY (CN) 2015-09-16 CN claimed
US-20240238423-A9 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. 2024-07-18 US disclosed
US-20240208967-A1 Pyrimidine or Pyridine Compounds, Preparation Method Therefor and Pharmaceutical Uses Thereof INVENTISBIO CO LTD (CN) 2024-06-27 US disclosed
US-12018093-B2 Hemiasterlin derivatives and antibody-drug conjugates including same Sumitomo Pharma Co., Ltd. (JP) 2024-06-25 US disclosed
US-12018093-B2 Hemiasterlin derivatives and antibody-drug conjugates including same Sumitomo Pharma Co., Ltd. (JP) 2024-06-25 US disclosed
EP-4328230-A2 AMINO ACID COMPOUNDS AND METHODS OF USE Pliant Therapeutics, Inc. (US) 2024-02-28 EP disclosed
US-11912713-B2 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same TREVENA, INC. (US) 2024-02-27 US disclosed
US-20240025849-A1 INHIBITORS OF NO PRODUCTION CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN (DE) 2024-01-25 US disclosed
US-11840550-B2 Silyl-biaryl phosphoramidites and methods of making BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-12-12 US disclosed
US-11840550-B2 Silyl-biaryl phosphoramidites and methods of making BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-12-12 US disclosed
US-7338951-B2 Pyridine compounds SYNTA PHARMACEUTICALS CORP. (US) 2008-03-04 US disclosed
US-20070213346-A1 Substituted 4-Alkyl-And 4-Alkanoyl-Piperidine Derivatives And Their Use As Neurokinin Antagonists JANSSEN PHARMACEUTICA, N.V. (BE) 2007-09-13 US disclosed
US-20070142380-A1 Viral Polymerase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-21 US disclosed
US-7229842-B2 Metal chelate containing compositions for use in chemiluminescent assays DADE BEHRING MARBURG GMBH (DE) 2007-06-12 US disclosed
US-7223785-B2 Viral polymerase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-29 US disclosed
EP-1757591-A1 CINNAMIDE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2007-02-28 EP disclosed
US-5567827-A 4-Hydroxyphenylthio derivatives, their preparation and their use for the preparation of aminoalkoxyphenylsulphonyl derivatives ELF SANOFI (FR) 1996-10-22 US disclosed
US-5508431-A 4-hydroxyphenylthio derivatives, their preparation and their use for the preparation of aminoalkoxyphenylsulphonyl derivatives ELF SANOFI (FR) 1996-04-16 US disclosed
US-5401855-A 4-hydroxyphenylthio derivatives, their preparation and their use for the preparation of aminoalkoxyphenylsulphonyl derivatives ELF SANOFI (FR) 1995-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11840550-B2 Silyl-biaryl phosphoramidites and methods of making PAICS, PGLS, SCLY IDO1 1709/4885MEN1 1703/4885KMT2A 1728/4885
US-20240208967-A1 Pyrimidine or Pyridine Compounds, Preparation Method Therefor and Pharmaceutical Uses Thereof EGFR, WEE1, DPYD IDO1 3486/4885MEN1 4405/4885KMT2A 4145/4885
US-11912713-B2 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same OPRD1, OPRM1, OPRK1 IDO1 218/4885MEN1 3740/4885KMT2A 1132/4885
US-20240025849-A1 INHIBITORS OF NO PRODUCTION NOS2, NOS1, NOS3 IDO1 119/4885MEN1 4048/4885KMT2A 2994/4885
US-20070142380-A1 Viral Polymerase Inhibitors POLM, POLR2H, POLR2A IDO1 1338/4885MEN1 2630/4885KMT2A 1908/4885
US-20240238423-A9 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS BCL2A1, BCL2L1, BCL3 IDO1 174/4885MEN1 2077/4885KMT2A 1422/4885
US-12018093-B2 Hemiasterlin derivatives and antibody-drug conjugates including same FCGRT, QARS1, INHA IDO1 1444/4885MEN1 1029/4885KMT2A 496/4885
US-20070213346-A1 Substituted 4-Alkyl-And 4-Alkanoyl-Piperidine Derivatives And Their Use As Neurokinin Antagonists NPSR1, VIP, OPRK1 IDO1 951/4885MEN1 2100/4885KMT2A 1187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.